Your browser doesn't support javascript.
loading
Modeling human pancreatic beta cell dedifferentiation.
Diedisheim, Marc; Oshima, Masaya; Albagli, Olivier; Huldt, Charlotte Wennberg; Ahlstedt, Ingela; Clausen, Maryam; Menon, Suraj; Aivazidis, Alexander; Andreasson, Anne-Christine; Haynes, William G; Marchetti, Piero; Marselli, Lorella; Armanet, Mathieu; Chimienti, Fabrice; Scharfmann, Raphael.
Afiliação
  • Diedisheim M; INSERM U1016, Institut Cochin, Université Paris Descartes, 123 Boulevard de Port-Royal, 75014 Paris, France.
  • Oshima M; INSERM U1016, Institut Cochin, Université Paris Descartes, 123 Boulevard de Port-Royal, 75014 Paris, France.
  • Albagli O; INSERM U1016, Institut Cochin, Université Paris Descartes, 123 Boulevard de Port-Royal, 75014 Paris, France.
  • Huldt CW; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden.
  • Ahlstedt I; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden.
  • Clausen M; Discovery Sciences, Innovative Medicines and Early Development Biotech unit, AstraZeneca, Mölndal, Sweden.
  • Menon S; RDI Operations, Granta Park, AstraZeneca, Cambridge, UK.
  • Aivazidis A; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden.
  • Andreasson AC; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden.
  • Haynes WG; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden.
  • Marchetti P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Marselli L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Armanet M; Cell Therapy Unit, Hôpital Saint Louis, AP-HP, University Paris-Diderot, Paris, 75010, France.
  • Chimienti F; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden.
  • Scharfmann R; INSERM U1016, Institut Cochin, Université Paris Descartes, 123 Boulevard de Port-Royal, 75014 Paris, France. Electronic address: raphael.scharfmann@inserm.fr.
Mol Metab ; 10: 74-86, 2018 04.
Article em En | MEDLINE | ID: mdl-29472102
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Desdiferenciação Celular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Metab Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Desdiferenciação Celular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Metab Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França